The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Regulatory News (EML)

Share Price Information for Emmerson (EML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.90
Bid: 1.80
Ask: 2.00
Change: -0.10 (-5.00%)
Spread: 0.20 (11.111%)
Open: 2.00
High: 1.95
Low: 1.90
Prev. Close: 2.00
EML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Comprehensive Metallurgical Testwork

22 Jul 2019 07:00

RNS Number : 2001G
Emmerson PLC
22 July 2019
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

22 July 2019

Completion of Comprehensive Metallurgical Testing a Substantial De-Risking Milestonein the Development of Khemisset Potash Project

Highlights

·; Comprehensive metallurgical test work programme completed at end of June 2019

·; The flowsheet designed for the Khemisset Scoping Study (see announcement dated 20 November 2018) has been confirmed

o Recovery rates used in Scoping Study confirmed to be achievable

o Areas for further simplification and optimisation of process flowsheet have been identified

·; Results will inform the detailed process flow design and optimisation in the upcoming Feasibility Study

·; Work programme was completed by leading potash laboratory, Saskatoon Research Council ("SRC"), under supervision by Mr Don Larmour, one of the world's leading potash processing experts

·; Additional testing is planned during the ongoing engineering studies

Emmerson Plc, the Moroccan focused potash development company, is pleased to announce that it has completed the comprehensive metallurgical test work programme ("Met Testing" or "the Programme") for its world-class Khemisset Potash Project ("Khemisset" or "the Project"). As per previous guidance (see announcement dated 01 April 2019), the Programme was completed at the end of June and results were compiled and assimilated during July.

Key tests conducted in the Programme included:

- Comprehensive brine phase chemistry

- Decomposition rates at various particle sizes of Khemisset ores

- Liberation analysis

- Magnetic separation testing

The results of the Programme have confirmed that the proposed process flow sheet from the Scoping Study would enable the upgrading of ore from Khemisset into saleable quality Muriate of Potash ("MOP"). It also confirmed that the recovery rates assumed in the Scoping Study, of between 82% and 86% (depending on grade), are achievable. In addition, it confirmed there are likely to be areas for improvement to be incorporated into the Feasibility Study process flowsheet design, which is currently underway.

Hayden Locke, CEO of Emmerson, commented:

"The completion of an initial, comprehensive, metallurgical testing programme is one of the most important de-risking milestones for any development stage mining company and it is no exception for Emmerson".

"The results of our programme have confirmed the processing methods and recovery rates assumed in the Scoping Study, which showed that Khemisset is among the lowest capital cost and highest margin potash projects globally, with a post-tax NPV10 of US$1.14 billion. While we expect to complete some additional test work during the optimisation phase, it is significant that nothing was identified that would constrain our ability to produce saleable quality potash from a technical perspective."

"We are also very excited that there are a number of areas where we believe improvements can be made, which could significantly improve the already outstanding economics of the Project, especially in the area of energy consumption."

"We look forward to continuing to deliver on our many development objectives and timelines during this transformational year for the Company as we advance the world class Khemisset Project towards production."

The Programme was completed by the Saskatoon Research Council ("SRC") under the supervision of Emmerson's processing consultant, Don Larmour. SRC is a world leader in applied research, development and testing across many fields but particularly in potash mineral processing.

Mr Larmour, one of the world's leading potash processing experts, joined the Company earlier this year. Since then, he has carried out a detailed review of the Scoping Study and identified number of potential areas to further reduce Khemisset's extremely low capital and operating costs.

 

Summary of Metallurgical Test Work Programme and Results

Emmerson conducted a detailed planning and preparation process for the comprehensive metallurgical test work programme to ensure it was both rigorous and defendable in its methodology. It was also designed to take any currently observed variability in the ore composition into account to ensure that this is both understood and accounted for in the Feasibility Study process flowsheet design. This work will be of paramount importance in any future technical due diligences processes conducted by potential financing partners.

Test work conducted by SRC at its laboratory in Saskatoon included:

- Comprehensive brine phase chemistry of various ore compositions

- Decomposition rates at various particle sizes of Khemisset ores

- Liberation analysis

- Magnetic separation testing

Brine Phase Chemistry

Dissolution tests were carried out to assess the brine chemistry required to maximize recovery during decomposition. Synthetic brines were prepared, to which actual ore samples were added. Results showed that potash salts present at Khemisset decomposed as expected from the initial process flow sheet design completed for the Scoping Study. Optimal operating points were identified for decomposition brines to be targeted in operation.

 

Decomposition & Liberation Testing

Samples of ore from Khemisset's ongoing drilling programme were analysed, and individual potash bearing salts were isolated for testing. The ores were crushed to a range of particle sizes which allowed identification of the crush size where sufficient liberation was achieved to produce 95% decomposition. All tested material achieved the targeted decomposition levels. Carnallite samples required less crushing than anticipated to achieve targeted decomposition, which has positive implications for power consumption in operation. Rinneite samples required crushing in line with expectations.

Carnallite ores were crushed to sizes ranging from 0.25mm to 3.36mm. All size fractions tested, across samples from three different drill holes, achieved the target decomposition of 95%.

Rinneite ores achieved 100% decomposition when crushed to below 0.25mm, and approximately 70% decomposition when crushed below 0.5mm. It is expected that the precise crush size required to achieve the targeted 95% decomposition is approximately 0.4mm. This exact requirement will be investigated during detailed engineering and further optimisation related test work.  

 

Magnetic Separation Testing

Khemisset's ore in some locations contains the magnetically susceptible mineral Rinneite which contains potassium. Being able to process Rinneite effectively enhances the recovery capability of the overall project. As such, evaluating magnetic separation as a potential option for processing was considered beneficial, although the results of the test work programme show that the primary processing routes will likely not require it.

To test the efficacy of magnetic separation, ore was crushed to a size where liberation of various potash minerals is expected to be achieved (0.42mm). The crushed ore was then run over a magnet, which attracts only the potash bearing salts which also contain magnetic iron ions (Rinneite). The testing showed that magnetic separation is a feasible method of separating Rinneite from all non-magnetic material.

Although magnetic separation has been demonstrated to be a feasible method of ore separation, Emmerson's processing team believe the treatment of ores is possible without magnetic separation, simplifying the overall process circuit. However, the demonstrated effectiveness of magnetic separation gives flexibility for ongoing process evaluation.

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

Hayden Locke

Emmerson Plc

Tel: +44 (0) 207 236 1177

Edward McDermott

 

Jeremy King

 

Optiva Securities Limited

Broker

Tel: +44 (0) 3137 1904

Gaby Jenner

Melissa Hancock

St Brides Partners Ltd

Financial PR/IR

Tel: +44 (0) 20 7236 1177

 

 

 

 

**ENDS**

 

 

 

Notes to Editors

Emmerson's primary focus is on developing the Khemisset Potash Project located in Northern Morocco. The project has a large JORC Resource Estimate (2012) of 311.4Mt @ 10.2% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine. Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKDDDBBKBAOB
Date   Source Headline
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs
27th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20221:45 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Sep 20227:02 amRNSREX Retail Offer
26th Sep 20227:01 amRNSRenewal of Strategic Investment & Equity Placing
26th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
16th Aug 20224:18 pmRNSExercise of Options & Director/PDMR Shareholding
22nd Jul 20229:00 amRNSShare Options Scheme & Director Shareholdings
19th Jul 20225:05 pmRNSReplacement: Director/PDMR Shareholding
18th Jul 20224:00 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSQ2 Activities Update
7th Jul 202212:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSExercise of Warrants and Issue of Shares
13th Jun 20227:00 amRNSNotice of AGM and Posting of Annual Report
31st May 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
31st Mar 20227:00 amRNSQ1 Activities Update
15th Mar 20227:00 amRNSGrant of Share Options
21st Feb 20227:00 amRNSAppointment of Chief Financial Officer
16th Feb 20227:00 amRNSAppointment of Corporate Broker
27th Jan 20227:00 amRNSBasic Engineering Packages Awarded to Reminex S.A
25th Jan 20221:00 pmRNSPart Exercise of Options and Issue of Shares
31st Dec 20217:00 amRNSEnd of Year Newsletter
6th Dec 202112:45 pmRNSResult of AGM
6th Dec 202112:31 pmRNSResult of General Meeting
2nd Dec 20217:00 amRNSOperational Update: Khemisset Potash Project
29th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSIssue of Equity & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.